| Stereotactic Radiosurgery and Metformin in Patients With Borderline-Resectable or Locally-Advanced Pancreatic Cancer (NCT02153450) | Case Comprehensive Cancer Center | 2015-05-08 |
| Gemcitabine, Nab-paclitaxel and KPT-330 in Advanced Pancreatic Cancer (NCT02178436) | Mohammed Najeeb Al Hallak | 2014-10-31 |
| Dynamic Contrast Enhanced MRI in Patients With Advanced Breast or Pancreatic Cancer With Metastases to the Liver or Lung (NCT01741597) | City of Hope Medical Center | 2014-07-01 |
| Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer (NCT02047474) | Yale University | 2014-03-25 |
| Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic Cancer (NCT01924260) | Edward Kim | 2013-08-09 |
| CPI-613 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer (NCT01839981) | Wake Forest University Health Sciences | 2013-07-01 |
| Chemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients with Pancreatic Cancer (NCT01821612) | Alliance for Clinical Trials in Oncology | 2013-05-29 |
| Chemoradiation and Radiosurgery Boost in Treating Patients With Locally Advance Pancreatic Cancer That May or May Not be Removed by Surgery (NCT01739439) | Fox Chase Cancer Center | 2013-05-01 |
| Ultrasound-Guided Photodynamic Therapy With Photofrin & Gemcitabine for Patients With Locally Advanced Pancreatic Cancer (NCT01770132) | John DeWitt | 2013-04-19 |
| CPI-613 and Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer (NCT01835041) | Wake Forest University Health Sciences | 2013-04-01 |
| Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer (NCT01666730) | Case Comprehensive Cancer Center | 2013-02-21 |
| Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies (NCT01643499) | University of Chicago | 2012-03-26 |
| Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery (NCT01537107) | Mayo Clinic | 2012-03-05 |
| Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery (NCT01234935) | Translational Oncology Research International | 2011-01-13 |
| Sorafenib Tosylate and Everolimus in Treating Patients With Advanced Solid Tumors and Metastatic Pancreatic Cancer That Does Not Respond to Gemcitabine Hydrochloride (NCT00981162) | Roswell Park Cancer Institute | 2009-08-01 |
| Bortezomib and Carboplatin in Treating Patients With Metastatic Pancreatic Cancer (NCT00416793) | National Cancer Institute (NCI) | 2006-12-01 |
| Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With Gemcitabine (NCT00397787) | National Cancer Institute (NCI) | 2006-11-01 |
| Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas (NCT00085371) | National Cancer Institute (NCI) | 2004-07-01 |
| Paclitaxel and Bryostatin 1 in Treating Patients With Advanced Pancreatic Cancer (NCT00031694) | National Cancer Institute (NCI) | 2002-03-01 |